Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 8Completed 8Active not recruiting 4Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12Gastrointestinal 7Tumor-Agnostic 4Genitourinary 3Thoracic 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1Other 1Lymphoid 1Head & Neck 1Endocrine 1

Conditions

Opioid-Related Disorders 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 30Rituximab 23zanubrutinib 18fludarabine 14Vincristine 14venetoclax 13Prednisone 13blinatumomab 12Magnetic Resonance Spectroscopy 12Specimen Handling 11Doxorubicin 11obinutuzumab 10Bendamustine Hydrochloride 10Lenalidomide 9Dexamethasone 8polatuzumab vedotin 7glofitamab 7Methotrexate 7Radiotherapy 6Prednisolone 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Cytarabine 6Biopsy 6pirtobrutinib 5pegaspargase 5Immunotherapy, Adoptive 5tislelizumab 4tafasitamab 4selinexor 4orelabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Standard of Care × Lymphoid × Clear all
NCT07451197 2026-05-11

Family-Focused Study to Support Medication for Opioid Use Disorder

University of Wisconsin, Madison

Phase NA Not yet recruiting
338 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡